Jointown subsidiary invests in new industry fund for healthcare expansion

Jointown Pharmaceutical Group's controlling subsidiary, Beijing Jiuzhou Zhongchuang Technology Incubator Co., Ltd., is investing 10 million yuan in the Wuhan Chuchang Tongda Industry Investment Fund Partnership. This represents 7.14% of the fund's total subscribed capital of 140 million yuan. The fund aims to invest in innovative medical devices, consumer healthcare, life science services, and biopharmaceutical projects, focusing on growth and mature-stage companies while also considering early-stage ventures.

The investment constitutes a related party transaction as Beijing Chuchang Private Equity Fund Management Co., Ltd., the fund's general partner, and Beijing Dianjin Investment Co., Ltd., a limited partner and a major shareholder of Jointown, are both indirectly controlled by Jointown's controlling shareholder. The total amount of related party transactions with the same related party over the past 12 months is 369.49 million yuan.

The establishment of the industry fund is subject to business registration and fund filing procedures, introducing an element of uncertainty. Potential risks include macroeconomic conditions, industry policies, market fluctuations, and other force majeure factors, which could impact expected returns.